Eli Lilly and Co (1LLY.MI)
Milan - Milan Delayed price. Currency in EUR
Add to watchlist
As of 05:19PM CEST. Market open.
| Previous close | 698.20 |
| Open | 712.70 |
| Bid | 716.80 x N/A |
| Ask | 718.00 x N/A |
| Day's range | 709.30 - 719.00 |
| 52-week range | 516.00 - 754.00 |
| Volume | |
| Avg. volume | 199 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Eli Lilly First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Eli Lilly ( NYSE:LLY ) First Quarter 2024 Results Key Financial Results Revenue: US$8.77b (up 26% from 1Q 2023). Net...
PR NewswireLilly Declares Second-Quarter 2024 Dividend
The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock.
Yahoo FinanceAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
© 2024 Yahoo. All rights reserved.